Fraxin Alleviates LPS-Induced ARDS by Downregulating Inflammatory Responses and Oxidative Damages and Reducing Pulmonary Vascular Permeability
- 45 Downloads
Acute respiratory distress syndrome (ARDS) is a severe acute disease that threatens human health, and few drugs that can effectively treat this disease are available. Fraxin, one of the main active ingredients of Cortex Fraxini, a Chinese herbal medicine, has presented various pharmacological and biological activities. However, the effects of fraxin on ARDS have yet to be reported. In the present study, the protective effect of fraxin in lipopolysaccharide (LPS)-induced ARDS in a mouse model was analyzed. Results from the hematoxylin and eosin staining showed that fraxin might alleviate pathological changes in the lung tissues of mice with ARDS. ELISA and Western blot results revealed that fraxin might inhibit the production of inflammatory factors, namely, IL-6, TNF-α, and IL-1β, and the activation of NF-κB and MAPK signaling pathways in the lungs. Thus, the inflammatory responses were reduced. Fraxin might inhibit the increase in reactive oxygen species (ROS) and malondialdehyde (MDA), a product of lipid peroxidation in lung tissues. Fraxin might increase the superoxide dismutase (SOD) activity to avoid oxidative damage. Vascular permeability was also assessed through Evans blue dye tissue extravasation and fluorescein isothiocyanate–labeled albumin (FITC-albumin) leakage. Fraxin might inhibit the increase in pulmonary vascular permeability and relieve pulmonary edema. Fraxin was also related to the inhibition of the increase in matrix metalloproteinase-9, which is a glycocalyx-degrading enzyme, and the relief of damages to the endothelial glycocalyx. Thus, fraxin elicited protective effects on mice with LPS-induced ARDS and might be used as a drug to cure ARDS induced by Gram-negative bacterial infection.
KEY WORDSfraxin lipopolysaccharide ARDS inflammatory responses oxidative damages pulmonary vascular permeability
This work was supported by funding from the Natural Science Foundation of Shandong Province, China (ZR2017MH065), Young Teachers’ Training and Funding Project of Binzhou Medical University, and the National Natural Science Foundation of China (No. 81670078).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 2.Ferguson, N.D., E. Fan, L. Camporota, M. Antonelli, A. Anzueto, R. Beale, L. Brochard, R. Brower, A. Esteban, L. Gattinoni, A. Rhodes, A.S. Slutsky, J.L. Vincent, G.D. Rubenfeld, B.T. Thompson, and V.M. Ranieri. 2012. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Medicine 38 (10): 1573–1582.CrossRefGoogle Scholar
- 5.Kong, G., X. Huang, L. Wang, Y. Li, T. Sun, S. Han, W. Zhu, M. Ma, H. Xu, J. Li, X. Zhang, X. Liu, and X. Wang. 2016. Astilbin alleviates LPS-induced ARDS by suppressing MAPK signaling pathway and protecting pulmonary endothelial glycocalyx. International Immunopharmacology 36: 51–58.CrossRefGoogle Scholar
- 6.Hsu, H.T., Y.T. Tseng, Y.Y. Hsu, K.I. Cheng, S.H. Chou, and Y.C. Lo. 2015. Propofol attenuates lipopolysaccharide-induced reactive oxygen species production through activation of Nrf2/GSH and suppression of NADPH oxidase in human alveolar epithelial cells. Inflammation 38 (1): 415–423.CrossRefGoogle Scholar
- 9.Inagawa, R., H. Okada, G. Takemura, K. Suzuki, C. Takada, H. Yano, Y. Ando, T. Usui, Y. Hotta, N. Miyazaki, A. Tsujimoto, R. Zaikokuji, A. Matsumoto, T. Kawaguchi, T. Doi, T. Yoshida, S. Yoshida, K. Kumada, H. Ushikoshi, I. Toyoda, and S. Ogura. 2018. Ultrastructural alteration of pulmonary capillary endothelial glycocalyx during endotoxemia. Chest 154 (2): 317–325.CrossRefGoogle Scholar
- 11.Wang, H., B. Xiao, Z. Hao, and Z. Sun. 2016. Simultaneous determination of fraxin and its metabolite, fraxetin, in rat plasma by liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 1017-1018: 70–74.CrossRefGoogle Scholar
- 13.Niu, X., F. Liu, W. Li, W. Zhi, Q. Yao, J. Zhao, G. Yang, X. Wang, L. Qin, and Z. He. 2017. Hepatoprotective effect of fraxin against carbon tetrachloride-induced hepatotoxicity in vitro and in vivo through regulating hepatic antioxidant, inflammation response and the MAPK-NF-κB signaling pathway. Biomedicine & Pharmacotherapy 95: 1091–1102.CrossRefGoogle Scholar
- 14.Whang, W.K., H.S. Park, I. Ham, M. Oh, H. Namkoong, H.K. Kim, D.W. Hwang, S.Y. Hur, T.E. Kim, Y.G. Park, J.R. Kim, and J.W. Kim. 2005. Natural compounds, fraxin and chemicals structurally related to fraxin protect cells from oxidative stress. Experimental and Molecular Medicine 37 (5): 436–446.CrossRefGoogle Scholar
- 15.Schempp, H., D. Weiser, and E.F. Elstner. 2000. Biochemical model reactions indicative of inflammatory processes. Activities of extracts from Fraxinus excelsior and Populus tremula. Arzneimittel-Forschung/Drug Research 50 (4): 362–372.Google Scholar
- 16.Song, L., Z. Han, H. Cheng, J. Huan, L. Chen, J. Meng, X. Chen, and L. Xie. 2018. Therapeutic effects of different doses of methylprednisolone on smoke inhalation-induced acute lung injury in rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 30 (8): 754–759.Google Scholar
- 17.Wang, L., X. Huang, G. Kong, H. Xu, J. Li, D. Hao, T. Wang, S. Han, C. Han, Y. Sun, X. Liu, and X. Wang. 2016. Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS. Biochemical and Biophysical Research Communications 478 (2): 669–675.CrossRefGoogle Scholar
- 22.Aimbire, F., A.P. Ligeiro de Oliveira, R. Albertini, J.C. Corrêa, C.B. Ladeira de Campos, J.P. Lyon, J.A.Jr. Silva, and M.S. Costa. 2008. Low level laser therapy (LLLT) decreases pulmonary microvascular leakage, neutrophil influx and IL-1beta levels in airway and lung from rat subjected to LPS-induced inflammation. Inflammation 31 (3): 189–197.CrossRefGoogle Scholar
- 26.Peng, Z., S. Pati, D. Potter, R. Brown, J.B. Holcomb, R. Grill, K. Wataha, P.W. Park, H. Xue, and R.A. Kozar. 2013. Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1. Shock 40 (3): 195–202.CrossRefGoogle Scholar
- 29.Qi, D., X. Tang, J. He, D. Wang, Y. Zhao, W. Deng, X. Deng, G. Zhou, J. Xia, X. Zhong, and S. Pu. 2016. Omentin protects against LPS-induced ARDS through suppressing pulmonary inflammation and promoting endothelial barrier via an Akt/eNOS-dependent mechanism. Cell Death & Disease 7 (9): e2360.CrossRefGoogle Scholar